Subtle biological changes linked to Alzheimer’s disease may begin as early as the late 50s — decades before memory loss or other symptoms appear — according to new research from Mayo Clinic. The study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association,
Alzheimers
In a study published in Nature Communications, Mayo Clinic researchers have identified specific DNA-level changes in the brains of people with Alzheimer’s disease (AD). Using advanced biological analysis, the team mapped alterations in the brain’s regulatory landscape that may help explain why Alzheimer’s presents and progresses differently from person to
Alzheimer’s-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson’s-related protein, according to a Mayo Clinic study published in JAMA Network Open. The same pattern was not observed in men. The findings suggest that when alpha-synuclein — a protein linked to Parkinson’s disease — accumulates
In 2023, new-generation medications in international clinical trials have demonstrated slowing of the progression of Alzheimer’s Disease and its symptoms. The implications of these historic results for the global Alzheimer’s Disease pandemic will be presented at Arab Health 2024 by Harley Street’s Dr MacSweeney, co-founder and CEO of Re:Cognition Health’s, pioneering













